Skip to content
  • Home
  • About
  • Consulting
    • In Office Infection Control Consulting
    • eLearning
    • Online Consulting
    • Education Programs
    • Skype Consulting
  • Shop
    • All Products
    • eLearning Classes
    • Training Programs – DVD
    • Training Manuals
    • Newsletters
  • Blog
    • Germ Catcher Blog
    • Infection Control
    • CDC News
    • EID Journal
  • Events
  • Log In
  • Contact
Menu
  • Home
  • About
  • Consulting
    • In Office Infection Control Consulting
    • eLearning
    • Online Consulting
    • Education Programs
    • Skype Consulting
  • Shop
    • All Products
    • eLearning Classes
    • Training Programs – DVD
    • Training Manuals
    • Newsletters
  • Blog
    • Germ Catcher Blog
    • Infection Control
    • CDC News
    • EID Journal
  • Events
  • Log In
  • Contact
$0.00 0 Cart

Category: BSIs

New Recommendations for Use of 15-Valent and 20-Valent Pneumococcal Conjugant Vaccine, 2022

What is already known about this topic? Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for U.S. adults. Recommendations vary by […]

Report highlights need for maternal group B Strep vaccine

A new report from the World Health Organization (WHO) and the London School of Hygiene & Tropical Medicine (LSHTM) is calling for more urgency on efforts to develop a maternal […]

Postcards From the Edge: Lessons Taught by COVID-19

One thing that will haunt me and many health care personnel in both acute care and LTCFs forever is that so many people died without a family member at their […]

Despite Progress, three-quarters of a million infections threaten hospital patients each year

Despite Progress, three-quarters of a million infections threaten hospital patients each year National and state data detail threat of healthcare-associated infections and opportunities for further improvements. CDC released two reports today – one, …

© 2022 InCo and Associates International. All Rights Reserved | Powered by: Monster Development

Facebook-f Twitter Google-plus-g Pinterest